Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers

Cisplatin (CDDP) is one of the chemotherapeutic drugs being used to treat various cancers. Although effective in many cases, as high doses of CDDP cause cytotoxic effects that may worsen patients’ condition, therefore, a marker of sensitivity to CDDP is necessary to enhance the safety and efficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamimura, Kenya, Suda, Takeshi, Fukuhara, Yasuo, Okuda, Shujiro, Watanabe, Yu, Yokoo, Takeshi, Osaki, Akihiko, Waguri, Nobuo, Ishikawa, Toru, Sato, Toshihiro, Aoyagi, Yutaka, Takamura, Masaaki, Wakai, Toshifumi, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973578/
https://www.ncbi.nlm.nih.gov/pubmed/33737617
http://dx.doi.org/10.1038/s41598-021-85498-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973578/
https://www.ncbi.nlm.nih.gov/pubmed/33737617
http://dx.doi.org/10.1038/s41598-021-85498-7

Ejemplares similares